IGNITE

BAAR, Switzerland, June 30, 2026 Novocure has achieved a significant milestone in cancer treatment with the CE Mark approval...

CARY, N.C., June 30, 2026 Allucent, a global specialty Contract Research Organization (CRO) serving small and mid-sized biopharmaceutical companies,...